This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2016 France Therapeutic Drug Monitoring (TDM) Market is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 247 pages and 17 tables
SIMILAR MARKET STUDIES
2014-2018 US Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies-Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
This new 880-page report from VPGMarketResearch.com contains 37 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including: Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
November 2014 | $6200 | View Details >>
This new report from VPGMarketResearch.com provides analysis of Cannabinoids/Marijuana testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - ...
August 2015 | $0 | View Details >>
This new report from VPGMarketResearch.com provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include:
November 1999 | $0 | View Details >>
This new report from VPGMarketResearch.com provides strategic assessments of major coagulation product suppliers and emerging market entrants. The report presents analyses of major manufacturers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
July 2015 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research